Efficacy of Conventional and Novel Tyrosine Kinase Inhibitors for Uncommon EGFR Mutations—An In Vitro StudyHana Oiki(Kindai University), Yasuhiro Tsutani(Hiroshima University)CellsSeptember 4, 202510.3390/cells14171386Cited by 1SaveCiteExport RISWatch citationsRelated PapersPotential Utility of a 4th-Generation EGFR-TKI and Exploration of Resistance Mechanisms—An In Vitro Study|Biomedicines|2024|11Efficacy of Novel Third-Generation Tyrosine Kinase Inhibitors for Uncommon <em>EGFR</em> Mutations – an In Vitro Study|Preprints.org|2025|0